0 CHECKOUT

IV Fluid Transfer Drugs Devices and Markets

  • ID: 3803222
  • August 2016
  • Region: Global
  • Greystone Associates
1 of 3
IV Drug Administration was once Provided to Patients Only in Clinical Settings. However, Technology Developments and a Greater Emphasis on Cost Containment Over the Last 30 Years have Prompted a Shift to Providing this Therapy in Alternate Settings, Including the Home

Intravenous drug administration is one of the most common therapeutic procedures that patients in a hospital setting are likely to receive. Yet the lack of standardization among the various components, elements and steps that a caregiver must navigate to successfully execute a drug infusion have - according to several recent studies - contributed to medication errors and risks to patient safety.

IV drug administration was once provided to patients only in clinical settings. However, technology developments and a greater emphasis on cost containment over the last 30 years have prompted a shift to providing this therapy in alternate settings, including the home. IV fluid transfer drugs devices and markets is a detailed analysis of this evolving market.

What You Will Learn

- Analyzes and evaluates the global market for IV fluid transfer devices and assesses the probable impact of evolving regulatory, economic and demand factors

- Assesses approved IV fluid transfer devices and their market position

- Provides detailed descriptions of IV fluid transfer market segments and market factors

- Profiles sector companies, their product development activities, supply chain partners, business strategies, and collaboration partners

- Evaluates the impact of economic, technology, and regulatory factors on IV drug administration

Note: Product cover images may vary from those shown
2 of 3

1. Executive Summary

2. IV Administration Market Dynamics
- Evolution in Patient Care
- Demand Drivers
- Competitive Landscape
- Factors Limiting Growth

3. IV Fluid Transfer Device Design Factors
- Reducing Medication Errors
- Lyophilization and Reconstitution
- Provider and Patient Wellbeing

4. Device Profiles and Analysis
- I.V. Containers
- Fluid Transfer Devices
- Reconstitution Devices

5. Market Analysis and Assessment
- Autoimmune
- Blood Disorders
- Cardiovascular
- Metabolic
- Neurology
- Oncology

6. Market Factors
- Regulatory Factors
- Managed Care Initiatives

7. Product Evolution and Wearable Infusion Devices

8. Company Profiles

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Pall Corporation
  • Ferring Pharmaceuticals B.V.
  • Medtronic, Inc.
  • SkyePharma AG
  • Heron Therapeutics, Inc.
  • NIPRO Medical Corporation